307 related articles for article (PubMed ID: 32671737)
21. Synaptic, Mitochondrial, and Lysosomal Dysfunction in Parkinson's Disease.
Nguyen M; Wong YC; Ysselstein D; Severino A; Krainc D
Trends Neurosci; 2019 Feb; 42(2):140-149. PubMed ID: 30509690
[TBL] [Abstract][Full Text] [Related]
22. GBA deficiency promotes SNCA/α-synuclein accumulation through autophagic inhibition by inactivated PPP2A.
Du TT; Wang L; Duan CL; Lu LL; Zhang JL; Gao G; Qiu XB; Wang XM; Yang H
Autophagy; 2015; 11(10):1803-20. PubMed ID: 26378614
[TBL] [Abstract][Full Text] [Related]
23. Parkinson's disease: acid-glucocerebrosidase activity and alpha-synuclein clearance.
Blanz J; Saftig P
J Neurochem; 2016 Oct; 139 Suppl 1():198-215. PubMed ID: 26860955
[TBL] [Abstract][Full Text] [Related]
24. The Overcrowded Crossroads: Mitochondria, Alpha-Synuclein, and the Endo-Lysosomal System Interaction in Parkinson's Disease.
Lin KJ; Lin KL; Chen SD; Liou CW; Chuang YC; Lin HY; Lin TK
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31731450
[TBL] [Abstract][Full Text] [Related]
25. Polyamines in Parkinson's Disease: Balancing Between Neurotoxicity and Neuroprotection.
Vrijsen S; Houdou M; Cascalho A; Eggermont J; Vangheluwe P
Annu Rev Biochem; 2023 Jun; 92():435-464. PubMed ID: 37018845
[TBL] [Abstract][Full Text] [Related]
26. Treatment with Trehalose Prevents Behavioral and Neurochemical Deficits Produced in an AAV α-Synuclein Rat Model of Parkinson's Disease.
He Q; Koprich JB; Wang Y; Yu WB; Xiao BG; Brotchie JM; Wang J
Mol Neurobiol; 2016 May; 53(4):2258-68. PubMed ID: 25972237
[TBL] [Abstract][Full Text] [Related]
27. The Roles of
Zhang F; Wu Z; Long F; Tan J; Gong N; Li X; Lin C
Front Cell Neurosci; 2022; 16():927682. PubMed ID: 35875356
[TBL] [Abstract][Full Text] [Related]
28. Interaction of LRRK2 and α-Synuclein in Parkinson's Disease.
Daher JP
Adv Neurobiol; 2017; 14():209-226. PubMed ID: 28353286
[TBL] [Abstract][Full Text] [Related]
29. Deregulation of autophagy and vesicle trafficking in Parkinson's disease.
Sheehan P; Yue Z
Neurosci Lett; 2019 Apr; 697():59-65. PubMed ID: 29627340
[TBL] [Abstract][Full Text] [Related]
30. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
Perfeito R; Cunha-Oliveira T; Rego AC
Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292
[TBL] [Abstract][Full Text] [Related]
31. A Cleaning Crew: The Pursuit of Autophagy in Parkinson's Disease.
Parekh P; Sharma N; Gadepalli A; Shahane A; Sharma M; Khairnar A
ACS Chem Neurosci; 2019 Sep; 10(9):3914-3926. PubMed ID: 31385687
[TBL] [Abstract][Full Text] [Related]
32. Caffeic acid reduces A53T α-synuclein by activating JNK/Bcl-2-mediated autophagy in vitro and improves behaviour and protects dopaminergic neurons in a mouse model of Parkinson's disease.
Zhang Y; Wu Q; Zhang L; Wang Q; Yang Z; Liu J; Feng L
Pharmacol Res; 2019 Dec; 150():104538. PubMed ID: 31707034
[TBL] [Abstract][Full Text] [Related]
33. α-synuclein expression from a single copy transgene increases sensitivity to stress and accelerates neuronal loss in genetic models of Parkinson's disease.
Cooper JF; Spielbauer KK; Senchuk MM; Nadarajan S; Colaiácovo MP; Van Raamsdonk JM
Exp Neurol; 2018 Dec; 310():58-69. PubMed ID: 30194957
[TBL] [Abstract][Full Text] [Related]
34. Poly (ADP-ribose) polymerase 1 inhibition prevents neurodegeneration and promotes α-synuclein degradation via transcription factor EB-dependent autophagy in mutant α-synucleinA53T model of Parkinson's disease.
Mao K; Chen J; Yu H; Li H; Ren Y; Wu X; Wen Y; Zou F; Li W
Aging Cell; 2020 Jun; 19(6):e13163. PubMed ID: 32475059
[TBL] [Abstract][Full Text] [Related]
35. Lysosome-dependent pathways as a unifying theme in Parkinson's disease.
Tofaris GK
Mov Disord; 2012 Sep; 27(11):1364-9. PubMed ID: 22927213
[TBL] [Abstract][Full Text] [Related]
36. Dysfunction of the autophagy/lysosomal degradation pathway is a shared feature of the genetic synucleinopathies.
Manzoni C; Lewis PA
FASEB J; 2013 Sep; 27(9):3424-9. PubMed ID: 23682122
[TBL] [Abstract][Full Text] [Related]
37. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.
Büeler H
Exp Neurol; 2009 Aug; 218(2):235-46. PubMed ID: 19303005
[TBL] [Abstract][Full Text] [Related]
38. alpha-synuclein degradation by autophagic pathways: a potential key to Parkinson's disease pathogenesis.
Xilouri M; Vogiatzi T; Vekrellis K; Stefanis L
Autophagy; 2008 Oct; 4(7):917-9. PubMed ID: 18708765
[TBL] [Abstract][Full Text] [Related]
39. Trehalose induces autophagy via lysosomal-mediated TFEB activation in models of motoneuron degeneration.
Rusmini P; Cortese K; Crippa V; Cristofani R; Cicardi ME; Ferrari V; Vezzoli G; Tedesco B; Meroni M; Messi E; Piccolella M; Galbiati M; Garrè M; Morelli E; Vaccari T; Poletti A
Autophagy; 2019 Apr; 15(4):631-651. PubMed ID: 30335591
[TBL] [Abstract][Full Text] [Related]
40. Autophagy modulates SNCA/α-synuclein release, thereby generating a hostile microenvironment.
Poehler AM; Xiang W; Spitzer P; May VE; Meixner H; Rockenstein E; Chutna O; Outeiro TF; Winkler J; Masliah E; Klucken J
Autophagy; 2014; 10(12):2171-92. PubMed ID: 25484190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
